Association between HIV replication and serum leptin levels: An observational study of a cohort of HIV-1-infected South African women

Journal of the International AIDS Society

Volumn 13, Issue 1, 2010, Pages

  Azzoni, Livio ^a   Crowther, Nigel J ^b   Firnhaber, Cynthia ^b   Foulkes, Andrea S ^c   Yin, Xiangfan ^a   Glencross, Deborah ^b   Gross, Robert ^d   Kaplan, Mitch D ^e   Papasavvas, Emmanouil ^a   Schulze, Doreen ^b   Stevens, Wendy ^b   Van Der Merwe, Tessa ^f   Waisberg, Rita ^b   Sanne, Ian ^b   Montaner, Luis J ^a  

^a WISTAR INSTITUTE   (United States)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^c UNIVERSITY OF MASSACHUSETTS   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e Rosebank Hospital   (South Africa)

^f UNIVERSITY OF PRETORIA   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; LEPTIN; GLUCOSE;

ABDOMINAL SUBCUTANEOUS FAT; ADIPOSE TISSUE; ADULT; ANTHROPOMETRY; ARTICLE; BODY MASS; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DUAL ENERGY X RAY ABSORPTIOMETRY; EFFECTOR CELL; FEMALE; GLUCOSE METABOLISM; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN TISSUE; INNATE IMMUNITY; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSERVATIONAL STUDY; PRIORITY JOURNAL; SOUTH AFRICA; T LYMPHOCYTE ACTIVATION; VIRUS LOAD; VIRUS REPLICATION; WAIST CIRCUMFERENCE; BLOOD; BODY FAT DISTRIBUTION; GROWTH, DEVELOPMENT AND AGING; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; METABOLISM; VIROLOGY;

ADULT; BODY FAT DISTRIBUTION; CROSS-SECTIONAL STUDIES; FEMALE; GLUCOSE; HIV INFECTIONS; HIV-1; HUMANS; LEPTIN; LIPID METABOLISM; SOUTH AFRICA; VIRAL LOAD;

EID: 77957120755     PISSN: None     EISSN: 17582652     Source Type: Journal    
DOI: 10.1186/1758-2652-13-33     Document Type: Article

References (45)

1. Metabolic disturbances and wasting in the acquired immunodeficiency syndrome. C Grunfeld KR Feingold, N Engl J Med 1992 327 329 337 10.1056/NEJM199207303270506 1620172
2. Longitudinal anthropometric patterns among HIV-infected and HIV-uninfected women. JE Justman DR Hoover Q Shi T Tan K Anastos PC Tien SR Cole C Hyman R Karim K Weber S Grinspoon, J Acquir Immune Defic Syndr 2008 47 312 319 10.1097/QAI.0b013e318162f597 18197125
3. Body image in women with HIV: a cross-sectional evaluation. JS Huang S Harrity D Lee K Becerra R Santos WC Mathews, AIDS Res Ther 2006 3 17 10.1186/1742-6405-3-17 16824226
4. Relationship between weight loss maintenance and changes in serum leptin levels. RR Wing MK Sinha RV Considine W Lang JF Caro, Horm Metab Res 1996 28 698 703 10.1055/s-2007-979881 9013745
5. Adipokines and the peripheral and neural control of energy balance. RS Ahima MA Lazar, Mol Endocrinol 2008 22 1023 1031 10.1210/me.2007-0529 18202144
6. A key role of leptin in the control of regulatory T cell proliferation. V De Rosa C Procaccini G Cali G Pirozzi S Fontana S Zappacosta A La Cava G Matarese, Immunity 2007 26 241 255 10.1016/j.immuni.2007.01.011 17307705
7. Leptin: at the crossroads of energy balance and systemic inflammation. AA Steiner AA Romanovsky, Prog Lipid Res 2007 46 89 107 10.1016/j.plipres.2006.11. 001 17275915
8. Leptin stimulates the oxidative burst in control monocytes but attenuates the oxidative burst in monocytes from HIV-infected patients. C Sanchez-Pozo J Rodriguez-Bano A Dominguez-Castellano MA Muniain R Goberna V Sanchez-Margalet, Clin Exp Immunol 2003 134 464 469 10.1111/j.1365-2249.2003.02321.x 14632752
9. Serum leptin levels in the acquired immunodeficiency syndrome. C Grunfeld M Pang JK Shigenaga P Jensen R Lallone J Friedman KR Feingold, J Clin Endocrinol Metab 1996 81 4342 4346 10.1210/jc.81.12.4342 8954039
10. Serum leptin concentrations in human immunodeficiency virus-infected men with low adiposity. KE Yarasheski JJ Zachwieja MM Horgan WG Powderly JV Santiago M Landt, Metabolism 1997 46 303 305 10.1016/S0026-0495(97)90258-4 9054474
11. Adiponectin and leptin levels in HIV-infected subjects with insulin resistance and body fat redistribution. DC Mynarcik T Combs MA McNurlan PE Scherer E Komaroff MC Gelato, J Acquir Immune Defic Syndr 2002 31 514 520 12473840
12. Relationship of fat distribution with adipokines in human immunodeficiency virus infection. LA Kosmiski P Bacchetti DP Kotler SB Heymsfield CE Lewis MG Shlipak R Scherzer C Grunfeld, J Clin Endocrinol Metab 2008 93 216 224 10.1210/jc.2007-1155 17940113
13. Leptin receptor (Ob-R) expression is induced in peripheral blood mononuclear cells by in vitro activation and in vivo in HIV-infected patients. V Sanchez-Margalet C Martin-Romero C Gonzalez-Yanes R Goberna J Rodriguez-Bano MA Muniain, Clin Exp Immunol 2002 129 119 124 10.1046/j.1365-2249.2002.01900.x 12100031
14. Energy expenditure and wasting in human immunodeficiency virus infection. DC Macallan C Noble C Baldwin SA Jebb AM Prentice WA Coward MB Sawyer TJ McManus GE Griffin, N Engl J Med 1995 333 83 88 10.1056/NEJM199507133330202 7777033
15. Prospective analysis of patterns of weight change in stage IV human immunodeficiency virus infection. DC Macallan C Noble C Baldwin M Foskett T McManus GE Griffin, Am J Clin Nutr 1993 58 417 424 8237855
16. Report on the global HIV/AIDS epidemic 2008: executive summary Geneva: Joint United Nations Programme on HIV/AIDS (UNAIDS) 2008
17. Monitoring reproducibility of single analysis, single platform CD4 cell counts in a high volume, low resource laboratory setting using sequential bead count rates. LE Scott DK Glencross, Cytometry B Clin Cytom 2005 67 31 32 16100713
18. Modeling Survival Data in Medical Research. D Collett, Modeling Survival Data in Medical Research Chapman & Hall/CRC Press 2003 83
19. Obesity in South Africa: the South African demographic and health survey. T Puoane K Steyn D Bradshaw R Laubscher J Fourie V Lambert N Mbananga, Obes Res 2002 10 1038 1048 10.1038/oby.2002.141 12376585
20. Early and delayed benefits of HIV-1 suppression: timeline of recovery of innate immunity effector cells. L Azzoni J Chehimi L Zhou AS Foulkes R June VC Maino A Landay C Rinaldo LP Jacobson LJ Montaner, AIDS 2007 21 293 305 10.1097/QAD.0b013e328012b85f 17255736
21. Changes in levels of immune activation and reconstitution markers among HIV-1-infected Africans receiving antiretroviral therapy. S Koblavi-Deme M Maran N Kabran MY Borget M Kalou L Kestens C Maurice M Sassan-Morokro ER Ekpini TH Roels T Chorba JN Nkengasong, Aids 2003 17 Suppl 3 17 22 10.1097/00002030- 200317003-00003 14565605
22. Lipodystrophy in patients naive to HIV protease inhibitors. S Madge S Kinloch-de-Loes D Mercey MA Johnson IV Weller, AIDS 1999 13 735 737 10.1097/00002030-199904160-00020 10397574
23. Association of upper trunk and visceral adipose tissue volume with insulin resistance in control and HIV-infected subjects in the FRAM study. C Grunfeld D Rimland CL Gibert WG Powderly S Sidney MG Shlipak P Bacchetti R Scherzer S Haffner SB Heymsfield, J Acquir Immune Defic Syndr 2007 46 283 290 10.1097/QAI.0b013e31814b94e2 18167644
24. Body composition and metabolic changes in antiretroviral-naive patients randomized to didanosine and stavudine vs. abacavir and lamivudine. JC Shlay F Visnegarwala G Bartsch J Wang G Peng WM El-Sadr C Gibert D Kotler C Grunfeld S Raghavan, J Acquir Immune Defic Syndr 2005 38 147 155 10.1097/01.qai.0000143599. 64234.15 15671799
25. Metabolic complications associated with antiretroviral therapy. RG Jain ES Furfine L Pedneault AJ White JM Lenhard, Antiviral Res 2001 51 151 177 10.1016/S0166-3542(01)00148-6 11448728
26. A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors. A Carr K Samaras S Burton M Law J Freund DJ Chisholm DA Cooper, AIDS 1998 12 51 58 10.1097/00002030-199807000-00003 9619798
27. Predictors of disease progression in HIV infection: a review. SE Langford J Ananworanich DA Cooper, AIDS Res Ther 2007 4 11 10.1186/1742-6405-4-11 17502001
28. Immune activation and inflammation in HIV-1 infection: causes and consequences. V Appay D Sauce, J Pathol 2008 214 231 241 10.1002/path.2276 18161758
29. CD38 expression on CD8(+) T cells as a prognostic marker in vertically HIV-infected pediatric patients. GG Sherman LE Scott JS Galpin L Kuhn CT Tiemessen K Simmank S Meddows-Taylor TM Meyers, Pediatr Res 2002 51 740 745 12032270
30. Plasmacytoid dendritic cells in HIV infection: striking a delicate balance. P Fitzgerald-Bocarsly ES Jacobs, J Leukoc Biol 2010 87 609 620 10.1189/jlb.0909635 20145197
31. Evidence of a selective depletion of a CD16+ CD56+ CD8+ natural killer cell subset during HIV infection. B Lucia C Jennings R Cauda L Ortona AL Landay, Cytometry 1995 22 10 15 10.1002/cyto.990220103 7587727
32. Selective depletion of CD56(dim) NK cell subsets and maintenance of CD56(bright) NK cells in treatment-naive HIV-1-seropositive individuals. R Tarazona JG Casado O Delarosa J Torre-Cisneros JL Villanueva B Sanchez MD Galiani R Gonzalez R Solana J Pena, J Clin Immunol 2002 22 176 183 10.1023/A:1015476114409 12078859
33. Regional differences in protein production by human adipose tissue. P Arner, Biochem Soc Trans 2001 29 72 75 10.1042/BST0290072 11356130
34. Effects of HIV disease on lipid, glucose and insulin levels: results from a large antiretroviral-naive cohort. WM El-Sadr CM Mullin A Carr C Gibert C Rappoport F Visnegarwala C Grunfeld SS Raghavan, HIV Med 2005 6 114 121 10.1111/j.1468-1293.2005.00273.x 15807717
35. HIV infection and high-density lipoprotein: the effect of the disease vs the effect of treatment. H Rose I Woolley J Hoy A Dart B Bryant A Mijch D Sviridov, Metabolism 2006 55 90 95 10.1016/j.metabol.2005.07.012 16324925
36. Simple anthropometric measures correlate with metabolic risk indicators as strongly as magnetic resonance imaging-measured adipose tissue depots in both HIV-infected and control subjects. R Scherzer W Shen P Bacchetti D Kotler CE Lewis MG Shlipak SB Heymsfield C Grunfeld, Am J Clin Nutr 2008 87 1809 1817 18541572
37. Leptin promotes cell survival and activates Jurkat T lymphocytes by stimulation of mitogen-activated protein kinase. P Fernandez-Riejos R Goberna V Sanchez-Margalet, Clin Exp Immunol 2008 151 505 518 10.1111/j.1365-2249.2007. 03563.x 18234059
38. Role of leptin as an immunomodulator of blood mononuclear cells: mechanisms of action. V Sanchez-Margalet C Martin-Romero J Santos-Alvarez R Goberna S Najib C Gonzalez-Yanes, Clin Exp Immunol 2003 133 11 19 10.1046/j.1365-2249.2003.02190.x 12823272
39. TNFalpha expression of subcutaneous adipose tissue in obese and morbid obese females: relationship to adipocyte LPL activity and leptin synthesis. M Bullo P Garcia-Lorda J Peinado-Onsurbe M Hernandez D Del Castillo JM Argiles J Salas-Salvado, Int J Obes Relat Metab Disord 2002 26 652 658 10.1038/sj.ijo.0801977 12032749
40. Systemic inflammation, adipose tissue tumor necrosis factor, and leptin expression. M Bullo P Garcia-Lorda I Megias J Salas-Salvado, Obes Res 2003 11 525 531 10.1038/oby.2003.74 12690081
41. Nef and TNFalpha are coplayers that favor HIV-1 replication in monocytic cells and primary macrophages. G Herbein A Varin A Larbi C Fortin U Mahlknecht T Fulop BB Aggarwal, Curr HIV Res 2008 6 117 129 10.2174/157016208783884985 18336259
42. Adipose tissue as an immunological organ: Toll-like receptors, C1q/TNFs and CTRPs. A Schaffler J Scholmerich B Salzberger, Trends Immunol 2007 28 393 399 10.1016/j.it.2007.07.003 17681884
43. Markers of inflammation are negatively correlated with serum leptin in rheumatoid arthritis. C Popa MG Netea TR Radstake PL van Riel P Barrera JW van der Meer, Ann Rheum Dis 2005 64 1195 1198 10.1136/ard.2004.032243 15731289
44. Decreased plasma leptin concentrations in tuberculosis patients are associated with wasting and inflammation. R van Crevel E Karyadi MG Netea H Verhoef RH Nelwan CE West JW van der Meer, J Clin Endocrinol Metab 2002 87 758 763 10.1210/jc.87.2.758 11836317
45. Genetics of resistance to HIV infection: Role of co-receptors and co-receptor ligands. F Arenzana-Seisdedos M Parmentier, Semin Immunol 2006 18 387 403 10.1016/j.smim.2006.07.007 16978874